Functional and Physiological Responses to Multicomponent Exercise in Older Adults
1 other identifier
interventional
40
1 country
1
Brief Summary
This study will examine functional and physiological responses to a 12-week multicomponent exercise program in community-dwelling older adults. Adults aged 60 to 81 years will be randomly assigned to either a multicomponent exercise group or a control group. The supervised exercise program will be performed twice weekly for 12 weeks and will include aerobic walking, resistance exercises, balance and agility training, flexibility exercises, and cool-down activities. Functional performance will be assessed using the six-minute walk test, the 30-second chair stand test, and the 8-Foot Up and Go test at baseline and after 12 weeks. Resting cardiac autonomic function will be assessed using heart rate variability. In addition, an exploratory responder-non-responder analysis will be conducted to examine whether baseline heart rate variability is associated with individual functional adaptations following the exercise program. This study may help identify physiological markers related to functional responsiveness to exercise in older adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2026
CompletedFirst Submitted
Initial submission to the registry
July 8, 2026
CompletedFirst Posted
Study publicly available on registry
July 14, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 21, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
July 14, 2026
July 1, 2026
4 months
July 8, 2026
July 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in six-minute walk distance
Functional walking capacity will be assessed using the six-minute walk test. The total distance walked in six minutes will be recorded in meters at baseline and after the 12-week intervention.
Baseline and 12 weeks
Secondary Outcomes (2)
Change in 30-second chair stand test performance
Baseline and after 12 weeks
Change in 8-foot Up-and-Go test performance
baseline and after 12 weeks
Other Outcomes (1)
Change in resting heart rate variability parameters
Baseline to 12 weeks
Study Arms (2)
multicomponent Exercise group
EXPERIMENTALParticipants are assigned to either a 12-week supervised multicomponent exercise group or a control group. Outcomes are assessed at baseline and after the 12-week intervention period.
Control Group
NO INTERVENTIONParticipants in the control group will maintain their usual daily activities during the 12-week study period and will not receive the supervised multicomponent exercise program.
Interventions
Participants in the exercise group will complete a supervised multicomponent exercise program twice weekly for 12 weeks. Each session will last approximately 45 to 50 minutes and include warm-up, aerobic interval walking, resistance exercises, balance and agility training, flexibility exercises, and cool-down activities. Exercise intensity will be monitored using the Borg Rating of Perceived Exertion scale and exercise difficulty will be progressively increased by increasing repetitions, walking duration, walking pace, and task complexity.
Eligibility Criteria
You may qualify if:
- being 60 years of age or older,
- being able to walk independently,
- not having any serious cardiovascular, neurological, or musculoskeletal disease that would prevent exercise.
- do not use medications that may affect autonomic nervous system function
You may not qualify if:
- diagnosed cardiac arrhythmia,
- uncontrolled hypertension,
- use of medications that may affect autonomic nervous system function,
- inability to perform functional performance tests.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Canakkale Onsekiz Mart University
Çanakkale, 17100, Turkey (Türkiye)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 8, 2026
First Posted
July 14, 2026
Study Start
June 1, 2026
Primary Completion (Estimated)
September 21, 2026
Study Completion (Estimated)
September 30, 2026
Last Updated
July 14, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share